TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum β-lactamases

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 4181-4183

  Robin, Frédéric ^a,b,d   Delmas, Julien ^a,b   Brebion, Amélie ^a   Dubois, Damien ^a,b   Constantin, Jean Michel ^c   Bonnet, Richard ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c HÔTEL DIEU   (France)

^d Faculté de Médecine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE TEM 12; BETA LACTAMASE TEM 158; BETA LACTAMASE TEM 35; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOTAXIME PLUS CLAVULANIC ACID; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; UNCLASSIFIED DRUG;

ACCURACY; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; ENZYME MODIFICATION; HYDROLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CATALYSIS; CEFTAZIDIME; CLAVULANIC ACID; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; ISOENZYMES; KINETICS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 35848929952     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00614-07     Document Type: Article

References (11)

1. Chaibi, E. B., D. Sirot, G. Paul, and R. Labia. 1999. Inhibitor-resistant TEM β-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43:447-458.
2. Chanal, C., D. Sirot, H. Malaure, M. C. Poupart, and J. Sirot. 1994. Sequences of CAZ-3 and CTX-2 extended-spectrum β-lactamase genes. Antimicrob. Agents Chemother. 38:2452-2453.
3. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2007. Communiqué 2007. Comité de l'Antibiogramme de la Société Française de Microbiologie, Paris, France.
4. Fiett, J., A. Palucha, B. Miaczynska, M. Stankiewicz, H. Przondo-Mordarska, W. Hryniewicz, and M. Gniadkowski. 2000. A novel complex mutant β-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum β-lactamase-producing Klebsiellae. Antimicrob. Agents Chemother. 44:1499-1505.
5. TEM genes and their promoters. Antimicrob. Agents Chemother. 44:3232-3234.
6. Neuwirth, C., S. Madec, E. Siebor, A. Pechinot, J. M. Duez, M. Pruneaux, M. Fouchereau-Peron, A. Kazmierczak, and R. Labia. 2001. TEM-89 β-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3. Antimicrob. Agents Chemother. 45:3591-3594.
7. Poirel, L., H. Mammeri, and P. Nordmann. 2004. TEM-121, a novel complex mutant of TEM-type β-lactamase from Enterobacter aerogenes. Antimicrob. Agents Chemother. 48:4528-4531.
8. Robin, F., J. Delmas, M. Archambaud, C. Schweitzer, C. Chanal, and R. Bonnet. 2006. CMT-type β-lactamase TEM-125, an emerging problem for extended-spectrum β-lactamase detection. Antimicrob. Agents Chemother. 50:2403-2408.
9. Robin, F., J. Delmas, C. Chanal, D. Sirot, J. Sirot, and R. Bonnet. 2005. TEM-109 (CMT-5), a natural complex mutant of TEM-1 β-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5). Antimicrob. Agents Chemother. 49:4443-4447.
10. Robin, F., J. Delmas, C. Schweitzer, O. Tournilhac, O. Lesens, C. Chanal, and R. Bonnet. 2007. Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient. Antimicrob. Agents Chemother. 51:1304-1309.
11. Sirot, D., C. Recule, E. B. Chaibi, L. Bret, J. Croize, C. Chanal-Claris, R. Labia, and J. Sirot. 1997. A complex mutant of TEM-1 β-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 41:1322-1325.